Related Experiment Video
Updated: Jul 20, 2026
07:08
Establishment of a Robust and Reproducible Model of Radiation-Induced Skin and Muscle Fibrosis
Published on: August 31, 2022
1.9K
Toxic epidermal necrolysis after radiotherapy for pleomorphic liposarcoma
Fatema S Esaa, Julia G Hobson, Regina N Matar
1Department of Dermatology, University of Rochester Medical Center, Rochester, NY. Kathryn_Somers@urmc.rochester.edu.
Dermatology Online Journal
|March 11, 2020
Summary
Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) are severe drug reactions. Understanding their T-cell mechanisms and genetic links is key for identifying at-risk patients and improving treatment.
Area of Science:
- Immunodermatology
- Pharmacogenomics
Background:
- Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe, life-threatening cutaneous adverse drug reactions.
- These conditions are often triggered by specific medications, necessitating a thorough understanding of their underlying mechanisms.
Observation:
- Recent research has elucidated key pathophysiological pathways, including drug-specific T-cell mediated cytotoxicity.
- Genetic factors, such as human leukocyte antigen (HLA) and non-HLA genes, along with T-cell receptor (TCR) restriction, play a significant role in SJS/TEN susceptibility.
- Emerging evidence suggests potential contributions from radiotherapy and rare malignancies.
Findings:
- The study highlights the complex interplay of genetic predisposition and immune responses in SJS/TEN pathogenesis.
- Mechanisms involving T-cell activation and drug-specific cytotoxicity are increasingly understood.
- Genetic linkages provide insights into patient risk stratification.
Implications:
- A comprehensive understanding of SJS/TEN etiology is crucial for effective treatment strategies.
- Identifying at-risk individuals through genetic and clinical factors can guide preventative measures.
- Further research into the roles of radiotherapy and malignancy may reveal novel therapeutic targets.
